Evidera, a leading provider of evidence-based solutions for the healthcare industry, is pleased to announce that Colleen A. McHorney, PhD – an internationally-recognized thought leader in the fields of health outcomes assessment and medication adherence – has joined Evidera as a Senior Research Leader in its Outcomes Research group. Dr. McHorney will be leading clinical outcome assessment as well as medication adherence projects for pharmaceutical clients.

Dr. McHorney’s 30-year career has focused on integrating the patient voice into health research and has spanned the methodology gamut, from qualitative research to advanced classical and modern psychometric techniques. A trained psychometrician and health services researcher, Dr. McHorney has conceptualized and developed numerous patient-centered quality-of-life and quality-of-care measures, both generic and disease-specific. She has published more than 80 peer-reviewed articles, 6 book chapters, has made over 115 presentations at professional conferences, and has been cited more than 11,000 times, making her one of the most highly cited health services researchers in the world.

“Colleen is a star in the field of outcomes research, and we are extremely excited to have her join our team,” said Margaret K. Vernon, PhD, Vice President and General Manager, Outcomes Research.

Dr. McHorney began her career at The Health Institute, New England Medical Center, and the Harvard School of Public Health. At The Health Institute, she was the co-architect, with John E. Ware, Jr., of the early psychometric work published on the MOS SF-36 Health Survey. Dr. McHorney held tenured positions at the Indiana University School of Medicine, the University of Kentucky, and the University of Wisconsin-Madison School of Medicine; was a senior scientist at the Regenstrief Institute; and a research career scientist in the VA Health Services Research program.

Prior to joining Evidera, Dr. McHorney was a Senior Scientist at ERT where she led the development and validation of patient-reported outcome (PRO) measures for pharmaceutical clients as well as regulatory support for PRO label claims. Dr. McHorney also led Covance’s market access scientific research on patient-reported outcomes (development, validation, and regulatory support) and Merck’s outcomes research on osteoporosis and scientific work on medication adherence from which she conceptualized, developed, and validated the Adherence Estimator®.

“I’m absolutely thrilled to be part of Evidera’s Outcomes Research group. The evolution and progression of the science of clinical outcomes assessment, and its interpretation and applications, can be attributable to Evidera’s scientists who have uniquely advanced the state-of-the-art of health outcomes research. I am truly humbled to be a part of this world-renowned group,” remarks Dr. McHorney.

Dr. McHorney will share her insights during a webinar on September 20, 2016, titled, “Medication Adherence and Outcomes Research: 21st Century Insights.” Additional details on the webinar can be found here.

Dr. McHorney’s bio is available on our website. Please email info@evidera.com for more information.